<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04268160</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201902486</org_study_id>
    <nct_id>NCT04268160</nct_id>
  </id_info>
  <brief_title>GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR</brief_title>
  <official_title>Glutathione Peroxidase Activity in Subjects With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to investigate the association of glutathione peroxidase (GPx) and
      severe aortic stenosis (AS), as well as the impact of transcatheter aortic valve replacement
      (TAVR) on GPx activity post-procedure. The burden of oxidative stress will be determined by
      the measurement of GPx, superoxide dismutase (SOD) and lipoprotein A (Lp(a)). We hypothesize
      GPx activity is reduced in participants with severe AS vs control groups and GPx activity is
      to increase after TAVR is performed.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Level of GPx in blood samples</measure>
    <time_frame>Baseline up to 6 months</time_frame>
    <description>Glutathione peroxidase activity levels measured from whole blood in U/L units in participants with severe aortic stenosis after transcatheter valve replacement compared with the matched population</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Glutathione Peroxidase Activity</condition>
  <condition>Aortic Stenosis</condition>
  <condition>Transcatheter Aortic Valve Replacement</condition>
  <arm_group>
    <arm_group_label>Patients with severe aortic stenosis undergoing TAVR</arm_group_label>
    <description>GPx activity levels will be measured on the day of TAVR procedure, the day of discharge, 1 month, and 6 months after the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without aortic stenosis</arm_group_label>
    <description>GPx activity levels will be measured on day of recruitment</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood draw to measure GPx activity</intervention_name>
    <description>Routine blood draw to measure levels of blood markers.</description>
    <arm_group_label>Patients with severe aortic stenosis undergoing TAVR</arm_group_label>
    <arm_group_label>Patients without aortic stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood draw to measure SOD activity</intervention_name>
    <description>Routine blood draw to measure levels of blood markers.</description>
    <arm_group_label>Patients with severe aortic stenosis undergoing TAVR</arm_group_label>
    <arm_group_label>Patients without aortic stenosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood draw to measure Lp(a) levels</intervention_name>
    <description>Routine blood draw to measure levels of blood markers.</description>
    <arm_group_label>Patients with severe aortic stenosis undergoing TAVR</arm_group_label>
    <arm_group_label>Patients without aortic stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study participants with severe aortic stenosis undergoing TAVR. They will be matched with
        patients without aortic stenosis based on age, gender, race, and co-morbidities (including
        stroke, history of coronary artery disease, heart failure, diabetes, hypertension, and
        other valvular diseases).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  Patients with severe AS including participants with low flow, low gradient severe AS
             and paradoxical severe AS

          -  Patients meeting criteria for TAVR procedure

        Exclusion Criteria:

          -  Previous aortic valve replacement (surgical or TAVR)

          -  Participants undergoing chemotherapy

          -  End stage liver disease/cirrhosis (liver produces GSH)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chinelo Udemgba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chinelo Udemgba, MD</last_name>
    <phone>601-870-0143</phone>
    <email>chinelo.udemgba@jax.ufl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Chinelo Udemgba, MD</last_name>
      <phone>601-870-0143</phone>
      <email>chinelo.udemgba@jax.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Chinelo Udemgba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Redfors, B. A. (2017). Biomarkers in Aortic Stenosis: A systematic Review. Structural Heart. The Journal of the Heart Team, 1-13.</citation>
  </reference>
  <reference>
    <citation>Otto CM. Aortic stenosis and hyperlipidemia: establishing a cause-effect relationship. Am Heart J. 2004 May;147(5):761-3.</citation>
    <PMID>15131528</PMID>
  </reference>
  <reference>
    <citation>Memet C, Gerede DM, Ozenci M, Akbulut IM, Acibuca A, Kiliçkap M, Erol C. Evaluation of the Role of Oxidative Stress in Degenerative Aortic Stenosis. J Heart Valve Dis. 2015 Jul;24(4):445-50.</citation>
    <PMID>26897814</PMID>
  </reference>
  <reference>
    <citation>Nimse, S. B. (2015). Free radicals, natural antioxidants, and their reaction mechanism. Royal Society of Chemistry, 27986-28006.</citation>
  </reference>
  <reference>
    <citation>Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ; AtheroGene Investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003 Oct 23;349(17):1605-13.</citation>
    <PMID>14573732</PMID>
  </reference>
  <reference>
    <citation>Bolzán AD, Bianchi MS, Bianchi NO. Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking. Clin Biochem. 1997 Aug;30(6):449-54.</citation>
    <PMID>9316738</PMID>
  </reference>
  <reference>
    <citation>Zheng KH, Tsimikas S, Pawade T, Kroon J, Jenkins WSA, Doris MK, White AC, Timmers NKLM, Hjortnaes J, Rogers MA, Aikawa E, Arsenault BJ, Witztum JL, Newby DE, Koschinsky ML, Fayad ZA, Stroes ESG, Boekholdt SM, Dweck MR. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis. J Am Coll Cardiol. 2019 May 7;73(17):2150-2162. doi: 10.1016/j.jacc.2019.01.070.</citation>
    <PMID>31047003</PMID>
  </reference>
  <reference>
    <citation>Arsenault BJ, Boekholdt SM, Dubé MP, Rhéaume E, Wareham NJ, Khaw KT, Sandhu MS, Tardif JC. Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort. Circ Cardiovasc Genet. 2014 Jun;7(3):304-10. doi: 10.1161/CIRCGENETICS.113.000400. Epub 2014 Apr 5.</citation>
    <PMID>24704946</PMID>
  </reference>
  <reference>
    <citation>Mahmaljy H, Tawney A, Young M. Transcatheter Aortic Valve Replacement (TAVR/TAVI, Percutaneous Replacement) [Updated 2019 Dec 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.</citation>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glutathione peroxidase, GPx, aortic stenosis, transcatheter aortic valve replacement, TAVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

